DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Amylamine is an investigational drug.
There have been 20 clinical trials for Amylamine. The most recent clinical trial was a Phase 3 trial, which was initiated on April 18th 2019.
The most common disease conditions in clinical trials are Depressive Disorder, Depression, and Depressive Disorder, Major. The leading clinical trial sponsors are CoMentis, Yale University, and Targacept Inc.
There is one US patent protecting this investigational drug and twenty international patents.
Recent Clinical Trials for Amylamine
|Cholinergic Mechanisms of Attention in Aging||Vanderbilt University Medical Center||Early Phase 1|
|Clinical Study to Assess the Efficacy and Safety of AT-5214 in the Treatment of Subjects With Palmar Hyperhidrosis||Atacama Therapeutics||Phase 2|
|Pilot Study of Mecamylamine for Autonomic Dysreflexia Prophylaxis||Wayne State University||Phase 4|
Top disease conditions for Amylamine
Top clinical trial sponsors for Amylamine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Amylamine||Get Started Free||Electrically conductive adhesives comprising at least one metal precursor||HENKEL AG & CO. KGAA (Duesseldorf, DE)||Get Started Free|
|Amylamine||Get Started Free||Coating methods using organosilica materials and uses thereof||EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (Annandale, NJ)||Get Started Free|
|Amylamine||Get Started Free||Ink jet recording method||Seiko Epson Corporation (JP)||Get Started Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Amylamine||China||CN103347974||2031-02-11||Get Started Free|
|Amylamine||European Patent Office||EP2487215||2031-02-11||Get Started Free|
|Amylamine||European Patent Office||EP2673330||2031-02-11||Get Started Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|